Ole Kristian Hjelstuen is the chief executive of Inven2, the tech transfer organisation owned by University of Oslo and Oslo University Hospital, which doesn’t just handle all of the typical research commercialisation aspects but also manages clinical trials at its partner institutions (which include all the health trusts in the South-Eastern Norway Regional Health Authority).

Ole’s been in the job since 2012, when he joined from GE Healthcare, and he also holds positions with the Oslo Cancer Cluster and incubator Aleap. He tells us how those last two add value to his job at Inven2, and why he also continues to be a professor of pharmaceutics at Arctic University of Norway.

Norway may be “on the edge of Europe”, as Ole remarks in this episode, but it is very much punching above its weight not only in life sciences but also in more surprising sectors, like space tech.

“Funky Chunk” Kevin MacLeod (incompetech.com)

The post Ole Kristian Hjelstuen: Inven2 first appeared on Beyond the Breakthrough.